Detection of these malignant T-cell clones is critical for the diagnosis of CTCL, with TCm expressing CCR7+/L-selectin+ and TRm expressing CCR7+/L-selectin- [11]. Here, SELL is linked to primary cutaneous T-cell non-Hodgkin lymphoma.